Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol (SONAR-12)
This study has been completed.
UCB Pharma SA
ReSearch Pharmaceutical Services, Inc.
Information provided by (Responsible Party):
UCB, Inc. ( UCB Pharma SA )
First received: February 1, 2012
Last updated: March 18, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||March 2014|
|Primary Completion Date:||March 2014 (Final data collection date for primary outcome measure)|